IGM BIOSCIENCES INC. - COMMON STOCK

IGM Biosciences to Present at the Stifel 2021 Virtual Healthcare Conference

08 Nov 2021 07:00:01 By Nasdaq GlobeNewswire

IGM Biosciences Announces Third Quarter 2021 Financial Results and Provides Corporate Update

04 Nov 2021 09:21:39 By Nasdaq GlobeNewswire

IGM Biosciences Announces Leadership Appointments and Formation of IGM Infectious Diseases and IGM Autoimmunity and Inflammation Business Units

11 Oct 2021 16:05:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the 2021 Cantor Virtual Global Healthcare Conference

23 Sep 2021 16:05:00 By Nasdaq GlobeNewswire

IGM Biosciences to Participate in Three Upcoming Investor Conferences

07 Sep 2021 07:00:03 By Nasdaq GlobeNewswire

IGM Biosciences Announces Second Quarter 2021 Financial Results and Provides Corporate Update

09 Aug 2021 16:06:43 By Nasdaq GlobeNewswire

IGM Biosciences Announces the Appointment of Chris H. Takimoto, M.D., Ph.D., F.A.C.P., as Chief Medical Officer

29 Jul 2021 17:31:12 By Nasdaq GlobeNewswire

IGM Biosciences Announces Expansion of IgM Platform into Infectious Diseases, Publication of Preclinical Data in Nature Demonstrating Engineered IgM Antibody Antiviral Activity for the Treatment and Prevention of COVID-19

03 Jun 2021 07:01:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the Jefferies Virtual Healthcare Conference

26 May 2021 07:00:01 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the 2021 RBC Capital Markets Global Healthcare Conference

12 May 2021 07:00:01 By Nasdaq GlobeNewswire

IGM Biosciences Announces First Quarter 2021 Financial Results and Provides Corporate Update

06 May 2021 16:07:50 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the Truist Securities Life Sciences Summit

27 Apr 2021 07:00:01 By Nasdaq GlobeNewswire

IGM Biosciences Appoints George Gauthier as Chief Commercial Officer

12 Apr 2021 07:00:01 By Nasdaq GlobeNewswire

IGM Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

30 Mar 2021 16:17:25 By Nasdaq GlobeNewswire

IGM Biosciences to Announce Fourth Quarter and Year-end 2020 Financial Results and Host Conference Call and Webcast on March 30, 2021

24 Mar 2021 07:00:00 By Nasdaq GlobeNewswire

IGM Biosciences Appoints Lisa Decker, Ph.D., as Chief Business Officer

15 Mar 2021 07:00:02 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day

05 Feb 2021 07:00:00 By Nasdaq GlobeNewswire

IGM Biosciences Enters into Exclusive Licensing Agreement with Medivir for Birinapant

11 Jan 2021 18:00:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference

07 Jan 2021 07:00:00 By Nasdaq GlobeNewswire